期刊文献+

膀胱移行细胞癌组织中PTEN及VEGF的表达及相互关系 被引量:1

Expression and relationship between PTEN and VEGF in bladder transitional cell carcinoma
下载PDF
导出
摘要 目的探讨第10号染色体丢失的磷酸酶基因(PTEN)和血管内皮生长因子(VEGF)在膀胱移行细胞癌组织中的表达及其相互关系和临床意义。方法采用免疫组化SP法观察60例膀胱移行细胞癌石蜡标本中PTEN和VEGF的表达情况。结果28例(47%)呈PTEN蛋白阳性表达,41例(68%)呈VEGF阳性表达。随着病理分级、临床分期的增高,PTEN的阳性率降低(P<0.05);VEGF的阳性率相应增加但无统计学意义(P>0.05),但转移组和未转移组间有显著性差异(P<0.05);PTEN与VEGF两者之间呈明显负相关关系(r=-0.439,P<0.01)。结论膀胱癌组织中PTEN和VEGF的表达在肿瘤进展过程中起重要作用并有助于预后判断。 Objective To investigate the expression and relationship between phosphatase and tensin homology deleted on chromosome ten (PTEN) and vascular endothelial growth factor (VEGF) in bladder transitional cell carcinoma (BTCC) and their clinical significance. Methods Expression of PTEN and VEGF were detected in 60 specimens by immunohistochemistry test (SP method). Results The positive rate of PTEN was 47%(28/60) in BTCC; VEGF was 68%(41/60). With the pathological grade and the clinical stage of tumors being higher, the lower expression level of PTEN showed (P 〈0.05) ; while the expression of VEGF increased with no statistical significance ( P 〉0.05), but having a significant difference between specimens with lymph nodes metastasis and without lymph nodes metastasis ( P〈0.05). The expression of PTEN was negatively correlated with that of VEGF ( r = -0. 439, P〈0.01). Conclusion The expression of PTEN and VEGF in BTCC plays an important role during the progress of carcinoma and is helpful to evaluate the prognosis of patients.
出处 《中国康复理论与实践》 CSCD 2005年第10期811-813,共3页 Chinese Journal of Rehabilitation Theory and Practice
关键词 膀胱肿瘤 第10号染色体丢失的磷酸酶基因(PTEN) 血管内皮生长因子(VEGF) 免疫组织化学 bladder carcinoma phosphatase and tensin homology deleted on chromosome ten (PTEN) vascular endothelial growth factor (VEGF) immunohistochemistry
  • 相关文献

参考文献13

  • 1Axiotis CA, Monteagudo C, Merino MJ, et al. Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma[J].Am J Pathol,1991,138(4):799-806.
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 3Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J].Science,1997,275(5308):1943-1947.
  • 4Davies MA, Koul D, Dhesi H, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN[J].Cancer Res,1999,59(11):2551-2556.
  • 5Hopkin KA. Surprising function for the PTEN tomor suppressor[J].Science,1998,282(5391):1027-1030.
  • 6Khan S, Kumagai T, Vora J, et al. PTEN promoter is methylated in a proportion of invasive breast cancers[J].Int Cancer,2004,112(3):407-410.
  • 7McMenamin ME, Soung P, Perera S, et al. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high gleason score and advanced stage[J].Cancer Res,1999,59:4291-4296.
  • 8Liu J, Babaian DC ,Liebert M, et al. Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens[J].Mol Carcinog,2000,29(3):143-150.
  • 9Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF[J].Mol Biol Cell,1993,4(12):1317-1326.
  • 10Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis[J].Kidney Int,1999,56(3):794-814.

二级参考文献3

共引文献1364

同被引文献19

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部